ALCON's VEXOL OPHTHALMIC CORTICOSTEROID APPROVED DEC. 30 FOR TREATING POSTOP INFLAMMATION AND ANTERIOR UVEITIS; LAST 1994 NME RECEIVES PRIORITY REVIEW

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".